
U.S. cannabis laws projected to cost generic and brand pharmaceutical firms billions
Author(s) -
Ziemowit Bednarek,
Jacqueline Doremus,
Sarah S. Stith
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0272492
Subject(s) - legalization , cannabis , business , recreation , stock (firearms) , advertising , medicine , law , psychiatry , political science , engineering , mechanical engineering